2nd Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for AMIVAS, LLC

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Federal government relations service, strategy development and implementation relating to replacements for quinidine gluconate for treating severe malaria in the US.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Veterans VET

Federal government relations service, strategy development and implementation relating to replacements for quinidine gluconate for treating severe malaria in the US.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Federal government relations service, strategy development and implementation relating to replacements for quinidine gluconate for treating severe malaria in the US.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Homeland Security HOM

Federal government relations service, strategy development and implementation relating to replacements for quinidine gluconate for treating severe malaria in the US.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.